Open AccessThe AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells
Author(s) -
Fatma Şanli,
Neslisah Barlak,
Ahsen KILINÇ,
Özel Çapik,
Abdulmelik Aytatli,
Ömer Faruk Karataş
Publication year - 2020
Publication title -
the european research journal
Language(s) - English
Resource type - Journals
ISSN - 2149-3189
DOI - 10.18621/eurj.624088
Subject(s) - medicine , protein kinase b , cancer research , apoptosis , pi3k/akt/mtor pathway , annexin , cancer , clonogenic assay , context (archaeology) , cancer cell , viability assay , immunology , flow cytometry , biology , biochemistry , paleontology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom